1) Men with COVID-19 are more at risk for worse outcomes and death compared to women, independent of age. In a case series and public data set of COVID-19 patients, men represented a higher percentage of severe and critical cases as well as deaths.
2) Older age and pre-existing medical conditions were associated with higher severity and mortality for both COVID-19 and SARS patients. However, even after accounting for age and health status, men still had poorer outcomes for both diseases.
3) While men and women were equally likely to be infected with COVID-19 or SARS, male patients experienced higher mortality rates for both viruses.
Cryptic Disseminated Tuberculosis: a Secondary Analysis of Previous Hospital-...fahmi khan
The main purpose of this study was to describe the demographic and clinical features of cryptic disseminated TB; it was also aimed to shed light on diagnostic test, procedure results, organ involvement, and outcomes of cryptic disseminated TB in patients with confirmed disseminated TB.
Cryptic Disseminated Tuberculosis: a Secondary Analysis of Previous Hospital-...fahmi khan
The main purpose of this study was to describe the demographic and clinical features of cryptic disseminated TB; it was also aimed to shed light on diagnostic test, procedure results, organ involvement, and outcomes of cryptic disseminated TB in patients with confirmed disseminated TB.
To Assess the Severity and Mortality among Covid 19 Patients after Having Vac...YogeshIJTSRD
The severity and mortality of COVID 19 cases has been associated with the Three category such as vaccination status, severity of disease and outcome. Objective presently study was aimed to assess the severity and mortality among covid 19 patients. Methods Using simple lottery random method 100 samples were selected. From these 100 patients, 50 patients were randomly assigned to case group and 50 patients in control group after informed consents of relative obtained. Patients in the case group who being died after got COVID 19 whereas 50 patients in the control group participated who were survive after got infected from COVID 19 patients. Result It has three categories such as a Vaccination status For the vaccination status we have seen 59 patients were not vaccinated and 41 patients was vaccinated out of 100. b Incidence There were 41 patients were vaccinated whereas 59 patients were not vaccinated. c Severity In the case of mortality we selected 50 patients who were died from the Corona and I got to know that out of 50 patients there were 12 24 patients were vaccinated whereas 38 76 patients were non vaccinated. Although for the 50 control survival group total 29 58 patients were vaccinated and 21 42 patients was not vaccinated all graph start. Conclusion we have find out that those people who got vaccinated were less infected and mortality rate very low. Prof. (Dr) Binod Kumar Singh | Dr. Saroj Kumar | Ms. Anuradha Sharma "To Assess the Severity and Mortality among Covid-19 Patients after Having Vaccinated: A Retrospective Study" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-5 | Issue-5 , August 2021, URL: https://www.ijtsrd.com/papers/ijtsrd45065.pdf Paper URL: https://www.ijtsrd.com/other-scientific-research-area/other/45065/to-assess-the-severity-and-mortality-among-covid19-patients-after-having-vaccinated-a-retrospective-study/prof-dr-binod-kumar-singh
Traditional Chinese medicine for treatment of coronavirus disease 2019: a reviewLucyPi1
Abstract Since late December in 2019, the coronavirus disease 2019 has received extensive attention for its widespread prevalence. A number of clinical workers and researchers have made great efforts to understand the pathogenesis and clinical characteristics and develop effective drugs for treatment. However, no effective drugs with antiviral effects on severe acute respiratory syndrome coronavirus 2 have been discovered currently. Traditional Chinese medicine (TCM) has gained abundant experience in the treatment of infectious diseases for thousands of years. In this review, the authors summarized the clinical outcome, pathogensis and current application of TCM on coronavirus disease 2019. Further, we discussed the potential mechanisms and the future research directions of TCM against severe acute respiratory syndrome coronavirus 2.
Characteristics of COVID-19 and Tuberculosis Co-Infection: A Cross-Sectional ...semualkaira
Coronavirus disease 2019 (COVID-19) and Tuberculosis (TB) are two major infectious diseases posing significant
public health threats. This study aimed to investigate the clinical
features of COVID-19 and TB co-infected patients.
Clinical course and risk factors for mortality of adult inpatients with covid...BARRY STANLEY 2 fasd
Interpretation The potential risk factors of older age, high SOFA score, and d-dimer greater than 1 μg/mL could help
clinicians to identify patients with poor prognosis at an early stage. Prolonged viral shedding provides the rationale
for a strategy of isolation of infected patients and optimal antiviral interventions in the future.
To Assess the Severity and Mortality among Covid 19 Patients after Having Vac...YogeshIJTSRD
The severity and mortality of COVID 19 cases has been associated with the Three category such as vaccination status, severity of disease and outcome. Objective presently study was aimed to assess the severity and mortality among covid 19 patients. Methods Using simple lottery random method 100 samples were selected. From these 100 patients, 50 patients were randomly assigned to case group and 50 patients in control group after informed consents of relative obtained. Patients in the case group who being died after got COVID 19 whereas 50 patients in the control group participated who were survive after got infected from COVID 19 patients. Result It has three categories such as a Vaccination status For the vaccination status we have seen 59 patients were not vaccinated and 41 patients was vaccinated out of 100. b Incidence There were 41 patients were vaccinated whereas 59 patients were not vaccinated. c Severity In the case of mortality we selected 50 patients who were died from the Corona and I got to know that out of 50 patients there were 12 24 patients were vaccinated whereas 38 76 patients were non vaccinated. Although for the 50 control survival group total 29 58 patients were vaccinated and 21 42 patients was not vaccinated all graph start. Conclusion we have find out that those people who got vaccinated were less infected and mortality rate very low. Prof. (Dr) Binod Kumar Singh | Dr. Saroj Kumar | Ms. Anuradha Sharma "To Assess the Severity and Mortality among Covid-19 Patients after Having Vaccinated: A Retrospective Study" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-5 | Issue-5 , August 2021, URL: https://www.ijtsrd.com/papers/ijtsrd45065.pdf Paper URL: https://www.ijtsrd.com/other-scientific-research-area/other/45065/to-assess-the-severity-and-mortality-among-covid19-patients-after-having-vaccinated-a-retrospective-study/prof-dr-binod-kumar-singh
Traditional Chinese medicine for treatment of coronavirus disease 2019: a reviewLucyPi1
Abstract Since late December in 2019, the coronavirus disease 2019 has received extensive attention for its widespread prevalence. A number of clinical workers and researchers have made great efforts to understand the pathogenesis and clinical characteristics and develop effective drugs for treatment. However, no effective drugs with antiviral effects on severe acute respiratory syndrome coronavirus 2 have been discovered currently. Traditional Chinese medicine (TCM) has gained abundant experience in the treatment of infectious diseases for thousands of years. In this review, the authors summarized the clinical outcome, pathogensis and current application of TCM on coronavirus disease 2019. Further, we discussed the potential mechanisms and the future research directions of TCM against severe acute respiratory syndrome coronavirus 2.
Characteristics of COVID-19 and Tuberculosis Co-Infection: A Cross-Sectional ...semualkaira
Coronavirus disease 2019 (COVID-19) and Tuberculosis (TB) are two major infectious diseases posing significant
public health threats. This study aimed to investigate the clinical
features of COVID-19 and TB co-infected patients.
Clinical course and risk factors for mortality of adult inpatients with covid...BARRY STANLEY 2 fasd
Interpretation The potential risk factors of older age, high SOFA score, and d-dimer greater than 1 μg/mL could help
clinicians to identify patients with poor prognosis at an early stage. Prolonged viral shedding provides the rationale
for a strategy of isolation of infected patients and optimal antiviral interventions in the future.
Clinical characteristics of children with COVID-19 pneumoniaAI Publications
For this purpose, 75 children under the age of 18 were included in the study. The test for SARS-CoV-2 virus RNA was positive in the pathological material from the nasopharynx in all examined patients. The control group consisted of 15 healthy children. The patients included in the study were divided into 2 groups according to severity of disease: 49 (65.3%) patients with moderate COVID-19 were included in group I, 26 (34.7%) patients with severe COVID-19 - in group 2. Examination methods included anamnestic, clinical, instrumental and laboratory studies. The most common symptoms among children examined were fever (66 (88.0%)) and cough (74 (98.7%)). Rarely, muscle pains, loss of sense of smell and taste, headaches have been observed in older children. Intergroup comparison revealed higher levels of ferritin, D-dimer and fibrinogen in group II compared with group I. According to the results obtained, the course of the disease in children, in contrast to adults, is more favorable.
A Predictive Factor For Short-Term Outcome In Patients With COVID-19: CT Scor...JohnJulie1
This study enrolled 253 patients (63 died in the hospital, 190 were discharged). Compared to survivors, non-survivors were older, mostly male, had a higher prevalence of preexisting comorbidity, higher incidences of hypoxemia, lymphopenia and bacterial coinfection (p<0.001 for each). Regarding CT evaluations, non-survivors had higher CT scores (14.3±3.4 vs. 8.1±2.9), higher incidences of bronchial dilation with mosaic (34.9% vs. 10.5%), emphysema (28.6% vs. 10.5%), and diffuse opacity distribution (76.1% vs. 36.8%; all p<0.001).
A Predictive Factor For Short-Term Outcome In Patients With COVID-19: CT Scor...suppubs1pubs1
This study enrolled 253 patients (63 died in the hospital, 190 were discharged). Compared to survivors, non-survivors were older, mostly male, had a higher prevalence of preexisting comorbidity, higher incidences of hypoxemia, lymphopenia and bacterial coinfection (p<0.001 for each). Regarding CT evaluations, non-survivors had higher CT scores (14.3±3.4 vs. 8.1±2.9), higher incidences of bronchial dilation with mosaic (34.9% vs. 10.5%), emphysema (28.6% vs. 10.5%), and diffuse opacity distribution (76.1% vs. 36.8%; all p<0.001).
A Predictive Factor For Short-Term Outcome In Patients With COVID-19: CT Scor...suppubs1pubs1
This study enrolled 253 patients (63 died in the hospital, 190 were discharged). Compared to survivors, non-survivors were older, mostly male, had a higher prevalence of preexisting comorbidity, higher incidences of hypoxemia, lymphopenia and bacterial coinfection (p<0.001 for each). Regarding CT evaluations, non-survivors had higher CT scores (14.3±3.4 vs. 8.1±2.9), higher incidences of bronchial dilation with mosaic (34.9% vs. 10.5%), emphysema (28.6% vs. 10.5%), and diffuse opacity distribution (76.1% vs. 36.8%; all p<0.001).
COVID-19 (coronavirus disease 2019) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), previously known as 2019 novel coronavirus (2019-nCoV), a strain of coronavirus. The first cases were seen in Wuhan, China in December 2019 before spreading globally. The current outbreak was recognized as a pandemic on 11 March 2020.
The non-specific imaging findings are most commonly of atypical or organizing pneumonia, often with a bilateral, peripheral, and basal predominant distribution. No effective treatment or vaccine exists currently (March 2020).
A Meta-Analysis of COVID-19. This meta-analysis does not provide all of the answers regarding the appropriate course of action but is intended to help provide clarity assessing many of the MEDICAL considerations at play in the current pandemic. A responsible course of action addressing this pandemic must balance out a range of interconnected Medical, Economic and Social considerations.
It seems like you're providing information about the publication process of the International Journal of Advanced Publication Practices. This information outlines the fast publication schedule and peer-review process by the journal of the appears to prioritize a fast and efficient publication process while maintaining the quality and integrity of the research it publishes of the scopus.
The first three months of the COVID-19 epidemic:
Epidemiological evidence for two separate strains of SARSCoV-2 viruses spreading and implications for prevention
strategies
Similar to Gender Differences in Patient with COVID 19 (20)
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
1. ORIGINAL RESEARCH
published: 29 April 2020
doi: 10.3389/fpubh.2020.00152
Frontiers in Public Health | www.frontiersin.org 1 April 2020 | Volume 8 | Article 152
Edited by:
Zisis Kozlakidis,
International Agency for Research on
Cancer (IARC), France
Reviewed by:
Javier Carbajo-Lozoya,
Technical University of
Munich, Germany
Yunchang Shao,
China National GeneBank (BGI), China
*Correspondence:
Jin-Kui Yang
jkyang@ccmu.edu.cn
Shi Liu
1455019296@qq.com
Specialty section:
This article was submitted to
Infectious Diseases - Surveillance,
Prevention and Treatment,
a section of the journal
Frontiers in Public Health
Received: 23 March 2020
Accepted: 09 April 2020
Published: 29 April 2020
Citation:
Jin J-M, Bai P, He W, Wu F, Liu X-F,
Han D-M, Liu S and Yang J-K (2020)
Gender Differences in Patients With
COVID-19: Focus on Severity and
Mortality. Front. Public Health 8:152.
doi: 10.3389/fpubh.2020.00152
Gender Differences in Patients With
COVID-19: Focus on Severity and
Mortality
Jian-Min Jin1,2
, Peng Bai1,2
, Wei He3
, Fei Wu2
, Xiao-Fang Liu1
, De-Min Han4
, Shi Liu2
* and
Jin-Kui Yang5
*
1
Department of Respiratory and Critical Care Medicine, Beijing Tongren Hospital, Capital Medical University, Beijing, China,
2
Department of Internal Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology,
Wuhan, China, 3
Department of Critical Care Medicine, Beijing Tongren Hospital, Capital Medical University, Beijing, China,
4
Department of Otolaryngology and Head Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China,
5
Department of Medicine, Beijing Tongren Hospital, Capital Medical University, Beijing, China
Objective: The recent outbreak of Novel Coronavirus Disease (COVID-19) is reminiscent
of the SARS outbreak in 2003. We aim to compare the severity and mortality between
male and female patients with COVID-19 or SARS.
Study Design and Setting: We extracted the data from: (1) a case series of 43
hospitalized patients we treated, (2) a public data set of the first 37 cases of patients
who died of COVID-19 and 1,019 patients who survived in China, and (3) data of 524
patients with SARS, including 139 deaths, from Beijing in early 2003.
Results: Older age and a high number of comorbidities were associated with higher
severity and mortality in patients with both COVID-19 and SARS. Age was comparable
between men and women in all data sets. In the case series, however, men’s cases
tended to be more serious than women’s (P = 0.035). In the public data set, the number
of men who died from COVID-19 is 2.4 times that of women (70.3 vs. 29.7%, P = 0.016).
In SARS patients, the gender role in mortality was also observed. The percentage of
males were higher in the deceased group than in the survived group (P = 0.015).
Conclusion: While men and women have the same prevalence, men with COVID-19
are more at risk for worse outcomes and death, independent of age.
Keywords: SARS-CoV-2, COVID-19, SARS, morbidity, mortality, gender, male, female
WHAT IS NEW?
• This is the first preliminary study investigating the role of gender in morbidity and mortality in
patients with Novel Coronavirus Disease (COVID-19).
• Men are more at risk for worse outcomes and death, independent of age, with COVID-19.
• While males and females have the same prevalence of COVID-19, male patients have a
higher mortality.
2. Jin et al. Gender Differences in COVID-19
INTRODUCTION
In early December 2019, an outbreak of a novel coronavirus
disease (COVID-19) occurred in Wuhan city and then rapidly
spread throughout China, putting the world on alert. High-
throughput sequencing has revealed a novel β-coronavirus that is
currently named severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) (1), which resembles severe acute respiratory
syndrome coronavirus (SARS-CoV) (2). Most patients with
COVID-19 were Mild/Moderate patients who often experienced
dyspnea after 1 week. Severe patients progressed rapidly to
Critical conditions, which included symptoms such as acute
respiratory distress syndrome (ARDS), acute respiratory failure,
coagulopathy, septic shock, and metabolic acidosis.
Early identification of risk factors for Critical conditions is
urgently needed, not only to identify the defining clinical and
epidemiological characteristics with greater precision, but also to
facilitate the appropriate supportive care and prompt access to
the intensive care unit (ICU) if necessary.
The Chinese health authority has announced that the total
number of confirmed cases on the Chinese mainland has reached
76,936, and 2,442 people have died of the disease as of Feb 23.
Among the 2,442 deceased patients, most were old and two-
thirds were males, though the detailed data has not been reported
(3). This raises a question: Are men more susceptible to getting
and dying from COVID-19?
Here, we report the clinical characteristics of a recent case
series of 43 patients we treated and a public data set of the first 37
cases of those who died from COVID-19 and the 1,019 patients
who survived COVID-19. We aimed to compare the severity
and mortality in male and female patients with COVID-19 and
to explore the most useful prognostic factor for individualized
assessment. SARS-CoV-2 infection is reminiscent of the SARS-
CoV outbreak in early 2003, because both viruses attack cells via
the same ACE2 receptor (3). In this study, we also analyzed the
data of 524 SARS patients, including 139 deaths, from Beijing in
early 2003.
MATERIALS AND METHODS
Patients and Data Sources
Cases Series of COVID-19
The case series analysis covers 43 patients with COVID-19
who were treated at Wuhan Union Hospital by the medical
team of Beijing Tongren Hospital from January 29, 2020 to
February 15, 2020.
Public Data Set of COVID-19
The public data set covers the first 37 cases of patients who
died from COVID-19 and 1,019-cases of COVID-19 survivors
from the public data set from the Chinese Public Health Science
Data Center.
Cases Series of SARS
This study also included data of 524 SARS patients, including
139 deaths from 29 hospitals in early 2003. These patients were
hospitalized in Beijing between 25 March and 22 May 2003.
Diagnosis and clinical classification criteria and treatment
plan (trial version 5) of COVID-19 was launched by the National
Health Committee of the People’s Republic of China (http://www.
nhc.gov.cn/). The clinical classification of severity is as follows:
(1) Mild, only mild symptoms, imaging shows no pneumonia; (2)
Moderate, with fever, respiratory tract symptoms, and imaging
shows pneumonia; (3) Severe, meet any of the following signs:
(a) respiratory distress, respiratory rate ≥ 30 beats / min; (b) in
the resting state, finger oxygen saturation ≤ 93%) arterial blood
oxygen partial pressure (PaO2/oxygen concentration (FiO2) ≤
300 mmHg (1 mmHg = 0.133 kPa); (4) Critical, one of the
following conditions: (a) respiratory failure occurs and requires
mechanical ventilation, (b) Shock occurs, (c) ICU admission is
required for combined organ failure.
The study protocol was approved by the Ethics Committee of
Beijing Tongren Hospital, Capital Medical University.
Statistical Analysis
Data were expressed as mean ± SD, median [interquartile
range (IQR)], or percentages, as appropriate. To compare the
differences between the two groups, mean values and percentages
were used between the two groups by the Student t-test, Mann-
Whitney U-test, or chi-square (χ2) test. Kaplan–Meier survival
curves and the log-rank test was used for testing the survival rates
between males and females. Statistical analyses were performed
using the SAS software (version 9.4). P < 0.05 (two-tailed) was
considered to be statistically significant.
RESULTS
Case Series of Covid-19
The demographic and clinical characteristics are shown in
Table 1. The median age was 62 years (IQR, 51 to 70). Fever
(95.3%) and cough (65.1%) were the most common symptoms,
while diarrhea (16.3) was not common. 37.2% of patients had
at least one underlying disorder (i.e., hypertension, diabetes,
cardiovascular diseases, and chronic lung diseases). There is no
significant difference in median age between male and female
groups, but the maximum of the range of IQR is lower in
male (66 years in men vs. 73 years in women). Symptoms
and comorbidities were comparable between men and women.
As expected, men had a higher level of hemoglobin. However,
male patients also had elevated serum creatinine, white blood
cells, and neutrophils. Among the 43-case series, 13 (30.2%)
were diagnosed with Mild or Moderate pneumonia, while 14
(32.6%) and 16 (37.2%) were diagnosed with Severe and Critical
pneumonia, respectively. Chi-square (χ2) test for trend indicated
that men’s cases of COVID-19 tended to be more serious than
women’s (P = 0.035), according to the clinical classification of
severity (Figure 1).
Public Data Set of COVID-19
In the deceased patients, fever (86.5%) and cough (67.6%) were
common, while diarrhea was uncommon (18.9%).The median
period from symptom onset to death was 13 days (ranging of IQR
11 to 18 days). Of these deceased patients, 64.9% had at least one
Frontiers in Public Health | www.frontiersin.org 2 April 2020 | Volume 8 | Article 152
3. Jin et al. Gender Differences in COVID-19
TABLE 1 | Characteristics of a Case series of COVID-19.
Total
(n = 43)
Male
(n = 22)
Female
(n = 21)
P-
value
Age, median (range) – year 62 (51–70) 59 (51–66) 63 (52–73) 0.734
Symptoms
Fever – n (%) 41 (95.3) 21 (95.5) 20 (95.2) 0.490
Diarrhea – n (%) 7 (16.3) 3 (13.6) 4 (19.0) 0.946
Cough – n (%) 28 (65.1) 16 (72.7) 12 (57.1) 0.452
Comorbidities – n (%)
Hypertension – n (%) 10 (23.3) 6 (27.3) 4 (19.0) 0.782
Diabetes history – n (%) 5 (11.6) 4 (18.2) 1 (0.5) 0.370
Cardiovascular diseases – n (%) 4 (9.3) 2 (9.1) 2 (10.0) 0.634
Chronic lung diseases – n (%) 1 (0.2) 1 (0.5) 0 (0) 0.981
From symptom to diagnosis, median (range) – day 12 (8–14) 12 (7–13) 12 (10–14) 0.250
Aspartate aminotransferase – IU/l 42.4 ± 18.9 43.0 ± 15.3 41.7 ± 22.6 0.872
Alanine aminotransferase – IU/l 42.8 ± 19.0 45.0 ± 18.0 40.4 ± 19.5 0.590
Alkaline phosphatase – IU/l 53.4 ± 10.6 52.6 ± 11.9 54.3 ± 9.0 0.736
Lactate dehydrogenase – IU/l 369.4 ± 132.7 414.8 ± 136.2 321.8 ± 112.9 0.064
Serum creatinine – µmol/l 75.3 ± 21.1 90.4 ± 22.2 59.4 ± 10.9 0.000
Fasting Blood Glucose – mmol/l 7.3 ± 1.8 7.7 ± 2.0 6.7 ± 1.5 0.325
High sensitive C-reactive protein – mg/l 52.3 ± 27.8 58.9 ± 29.2 45.6 ± 25.3 0.323
White blood cells – ×109
/l 6.8 ± 2.2 7.7 ± 2.3 5.8 ± 1.5 0.027
Hemoglobin – g/l 128.8 ± 13.6 139.0 ± 11.2 117.6 ± 8.6 0.000
Platelets – ×109
/l 225.2 ± 57.4 230.4 ± 54.1 219.6 ± 60.0 0.682
Neutrophils – ×109
/l 5.4 ± 2.2 6.4 ± 2.4 4.3 ± 1.3 0.019
Lymphocytes – ×109
/l 1.0 ± 0.4 0.9 ± 0.3 1.1 ± 0.4 0.284
Data are presented as mean ± SD, medians (interquartile ranges, IQR) and no. (%). Bold values mean statistic difference between males and females.
FIGURE 1 | Trend data of clinical classification of severity in a Case series of
COVID-19. Numbers of cases of men or women in different clinical classes of
severity. Chi-square (χ2
) test for trend indicated that males tend to experience
more serious cases of COVID-19 than females according to the clinical
classification of severity including Mild+Moderate, Severe, and Critical.
underlying disorder (i.e., hypertension, diabetes, cardiovascular
disease, or chronic obstructive pulmonary disease) (Table 2).
The deceased patients were significantly older [median (IQR),
70.3 (65–81) years] and had a higher percentage of ≥65 years
(83.8%), in comparison to those who survived [47 (35–57) years
old and 13.2% ≥65 years]. COVID-19 was diagnosed at all
TABLE 2 | Characteristics of a Public data set of COVID-19 and a Cases series of
SARS, in 2003.
COVID-19 SARS
Deceased
(n = 37)
Survived
(n = 1019)
Deceased
(n = 139)
Survived
(n = 385)
Age, median (range) – year 70 (65–81)** 47 (35–57) 57 (45–69)††
32 (24–44)
Male – n (%) 26 (70.3)* 510 (50.0) 74 (53.2)†
163 (42.3)
Symptoms
Fever – n (%) 32 (86.5) 136 (97.8) 379 (98.4)
Diarrhea – n (%) 7 (18.9) 30 (21.6) 26 (6.8)
Cough – n (%) 25 (67.6) 107 (77.0) 185 (48.1)
Comorbidities – n (%) 24 (64.9) 79 (56.8)††
69 (17.9)
Hypertension – n (%) 18 (48.6) 64 (46.0)††
44 (11.4)
Diabetes history – n (%) 11(29.7) 30 (21.6)††
15 (3.9)
Cardiovascular disease – n (%) 8 (21.6) 40 (28.8)††
23 (6.0)
Chronic lung disease – n (%) 3 (8.1) 5 (3.6) 6 (1. 6)
From onset to death, median
(range) – day
13 (11–18) 15 (10–19)
Data are presented as medians (interquartile ranges, IQR) and n (%).
*p < 0.05, **p < 0.01, vs. COVID-19 survived patients.
†
p < 0.05, ††p < 0.01, vs. SARS survived patients.
ages. There were 30 (2.9%) pediatric patients (<14 years) in
the group of patients who survived. None of the 37 deceased
cases were pediatric patients (Table 2 and Figure 2A). Ages were
Frontiers in Public Health | www.frontiersin.org 3 April 2020 | Volume 8 | Article 152
4. Jin et al. Gender Differences in COVID-19
FIGURE 2 | Role of age and gender in morbidity and mortality in a Public data set of COVID-19. (A) The whole spectrum of age in patients who died from and
survived COVID. (B) Comparation of age between males and females in both patients who died from and survived COVID. (C) Gender distribution in both patients
who died from and survived COVID.
comparable between men and women in both patients who
deceased and survived (Figure 2B). Of the 37 deceased patients,
70.3% were men and 29.7% were woman. The number of men
was 2.4 times that of women in the deceased patients. While men
and women had the same susceptibility, men were more prone to
dying (χ2 test, P = 0.016) (Figure 2C).
Cases Series of SARS, in 2003
Between March 25 and May 22, 2003, a total of 524 SARS
patients, including 139 deaths, in the Beijing area were reported
from 29 hospitals enrolled in our analysis. Fever (98.4%) and
cough (76.9%) were the most common symptoms, while diarrhea
(6.7%) was not common. 57.0% of the patients had at least one
of the concomitant diseases including hypertension, diabetes,
cardiovascular diseases, and chronic lung diseases. The mean
duration from self-reported symptoms to death was 15 (IQR:
10–19) days. Table 2 summarizes the clinical and biochemical
characteristics of all SARS patients. The median age of the
deceased patients was much higher than that of the patients who
survived (57 vs. 32, P < 0.001). The rate of the concomitant
diseases in the deceased patients was also higher than that of
the patients who survived (57.0% vs. 17.9%, P < 0.001). While
the deceased patients were significantly older than the patients
who survived (Figure 3A), ages were comparable between men
and women in both patients who deceased and survived with
SARS (Figure 3B). The proportion of men was higher in the
deceased group (53.2%) than in the group who survived (42.3%)
(χ2 test, P = 0.027) (Figure 3C). Survival analysis showed that
men had a significantly higher mortality rate than women (31.2
vs. 22.6%) in this hospital-based cohort (hazard ratio [95% CI]
1.47 [1.05–2.06], P = 0.026) (Figure 3D).
DISCUSSION
Coronavirus is a large family of viruses that cause illnesses
ranging from the common cold to severe pneumonia, such
as SARS (2) and Middle East Respiratory Syndrome (MERS)
(4). SARS-CoV-2 was first identified in Wuhan, China, by the
Chinese Center for Disease Control and Prevention (CDC) (1).
Both epidemiological (5, 6) and clinical (7, 8) features of patients
with COVID-19 have recently been reported. However, little data
on the prognostic factors of COVID-19 have been reported.
In the Case series of COVID-19, consistent with previous
reports (8–10), older patients (≥65 years old), were more likely
to have a Severe type of COVID-19. Men tended to develop more
serious cases than women, according to the clinical classification
of severity. In the Public data set of COVID-19, we also found that
the percentage of older age (≥65 years) was much higher in the
deceased patients than in the patients who survived (83.8% in 37
deceased patients vs. 13.2% in 1,019 patients who survived).
The number of men is 2.4 times that of women in the deceased
patients. While men and women had the same susceptibility, men
were more prone to dying.
This is the first preliminary study investigating the role of
gender in morbidity and mortality of SARS-CoV-2 infection.
One study of 425 patients with COVID-19 indicated that 56%
Frontiers in Public Health | www.frontiersin.org 4 April 2020 | Volume 8 | Article 152
5. Jin et al. Gender Differences in COVID-19
FIGURE 3 | Role of age and gender in morbidity and mortality in a Cases series of SARS, in 2003. (A) The whole spectrum of age in patients who died from and
survived SARS. (B) Comparation of age between males and females in both patients who died from and survived SARS. (C) Gender distribution in both patients who
died from and survived SARS. (D) Survival analysis comparing mortality rates between male and female patients with SARS.
were males (5). Another study of 140 patients found that 50.7%
were males (9). In the present study, similar susceptibility
to SARS-CoV-2 between males and females was observed in
1,019 patients who survived the disease (50.0% males), collected
from a public data set and in a case series of 43 hospitalized
patients (51.2% males). Although the deceased patients were
significantly older than the patients who survived COVID-19,
ages were comparable between males and females in both the
deceased and the patients who survived. Therefore, gender is
a risk factor for higher severity and mortality in patients with
COVID-19, independent of age and susceptibility. This gender
factor, as well as higher incidences in men for most of the
diseases, could correlate with a general demographic fact of a
shorter life expectancy in men compared to women in China
and in the world in general. Although there is no significant
difference in median age between male and female groups,
the maximum of the range of IQR is lower in males in the
case series.
In early 2003, we participated in the Beijing Municipal
Medical Taskforce of SARS (11). Here, we re-analyzed the data
of a large population of 520 SARS patients, including 135
deaths in Beijing, and summarized the experience and lessons
for present use, because SARS-CoV-2 and SARS-CoV attack
cells via the same receptor, ACE2 (3). We have previously
reported that high protein expression of ACE2 receptor in
specific organs correlated with specific organ failures, indicated
by corresponding clinical parameters in SARS patients (11, 12).
It has been shown that circulating ACE2 levels are higher in men
than in women and in patients with diabetes or cardiovascular
diseases (13).
This study has some limitations. First, for severity analysis,
only a case series of 43 patients with SARS-CoV-2 was
included, because detailed patient information, particularly
regarding clinical outcomes, was unavailable in the public data
set. Second, for mortality analysis only the first 37 cases of
patients who died of SARS-CoV-2 were included. Due to the
urgent circumstances we are living in, there was no access
to unique, homogeneous data for COVID. It could affect the
analysis and any possible biased results. However, this is the
first preliminary analysis investigating the role of gender in
morbidity and mortality in patients with SARS-CoV-2. More
clinical and basic research regarding gender and other prognostic
factors for individualized assessment and treatment is needed
in the future.
Frontiers in Public Health | www.frontiersin.org 5 April 2020 | Volume 8 | Article 152